MIAMI, FL--(Marketwired - November 11, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announced today that it will host its Third Quarter 2016 financial results conference call on Monday, November 21, 2016 at 9:00 AM Eastern Time. Our management team will comment on Progressive Care's financial and operational results for third quarter ended September 30, 2016.
The Company has requested a filing deadline extension with OTC Markets. The Company is taking extra measures outside of its normal accounting procedures to ensure that the convertibility features of the Chicago Venture Note issued in the third quarter are properly valuated and comply with the highest possible financial reporting standards.
"The Company is committed to achieving the goal of auditing our financial statements for fiscal year 2016," stated S. Parikh Mars, CEO. "To this end, extra steps are being taken to use the most appropriate valuation model for the convertible note issued in the third quarter."
We encourage participants to pre-register for the conference call using the following link.
Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. A calendar reminder will be sent providing easy access on the day of the conference. Participants may pre-register at any time, including up to and after the call start time.
A live webcast will be available via the investor relations section of our website.
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.